Polycystic Kidney Disease
Clinical Care of Autosomal Dominant Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping

Autosomal Dominant Polycystic Kidney Disease Data Repository

Pilot study of genetic changes with Autosomal Dominant Polycystic Kidney Disease

IgA Nephropathy
Velcade® Therapy For Severe IgA Nephropathy

Diabetic Kidney Disease
FInerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease FIDELIO-DKD

SONAR: A Randomized, Multi-country, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy 

Chronic Kidney Disease
RENAL AID:  Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies


Familial Hypercholesterolemia

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

CASCADE FH Registry

Pancreatic Cancer
An Open-Label, Phase II Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients with Treatment-Resistant, Metastatic Pancreatic Adenocarcinoma or Colorectal Cancer

Colorectal Cancer
A Phase IIb, Nonrandomized, Open-Label Trial with Mouse Renal Adenocarcinoma (RENCA) Cell Containing Agarose-Agarose Macrobeads Compared with Best Supportive Care in Patients with Treatment-Resistant, Metastatic Colorectal Carcinoma

Prostate Cancer
An Open-Label, Phase II Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Subjects with Castration-Resistant Prostate Cancer Resistant to Taxanes (docetaxel, cabazitaxel) and evidence of disease progression on androgen-axis inhibition and/or immunotherapy in the form of sipuleucel-T.

 

For general information regarding the Clinical Research Program, please contact:
Betty-Jane Sloan, MA, CCRC, Clinical Research Manager
504 East 74th Street, 5th Floor
New York, NY  10021
Email: bjsloan@nyp.org
Phone:  646-317-0701